Suchergebnisse - "145155-23-3"

PubPharm (19)

1

Impact of interferon β-1b, interferon β-1a and fingolimod therapies on serum interleukins-22, 32α and 34 concentrations in patients with relapsing-remitting multiple sclerosis

enthalten in: Journal of neuroimmunology | 2019

von Abdel-Dayem, M. | Shaker, M. | Gameil, N.

2

Immune response during interferon beta-1b treatment in patients with multiple sclerosis who experienced relapses and those who were relapse-free in the START study

enthalten in: Journal of neuroimmunology | 2013

von Dhib-Jalbut, S. | Sumandeep, S. | Valenzuela, R. | +3

3

Biological response genes after single dose administration of interferon beta-1b to healthy male volunteers

enthalten in: Journal of neuroimmunology | 2008

von Hilpert, J. | Beekman, J. | Schwenke, S. | +7

4

The IgG subclass-specificities of anti-IFNbeta antibodies change with time and differ between the IFNbeta products in relapsing remitting multiple sclerosis patients

enthalten in: Journal of neuroimmunology | 2007

von Gibbs, E. | Oger, J.

5

Identification of interferon-beta antibodies in a reference laboratory setting : findings for 1144 consecutive sera

enthalten in: Journal of neuroimmunology | 2007

von Prince, H. | Lapé-Nixon, M. | Audette, C. | +1

CommentIn: J Neuroimmunol. 2008 Feb;194(1-2):5-6. - PMID 18031830

6

Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients

enthalten in: Journal of neuroimmunology | 2006

von Cross, A. | Stark, J. | Lauber, J. | +2

7

Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis

enthalten in: Journal of neuroimmunology | 2005

von Gilli, F. | Marnetto, F. | Caldano, M. | +5

8

Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy

enthalten in: Journal of neuroimmunology | 2004

von Fainardi, E. | Rizzo, R. | Melchiorri, L. | +7

9

The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b

enthalten in: Journal of neuroimmunology | 2002

von Brettschneider, J. | Ecker, D. | Bitsch, A. | +8

10

Low expression of interferon-stimulated genes in active multiple sclerosis is linked to subnormal phosphorylation of STAT1

enthalten in: Journal of neuroimmunology | 2002

von Feng, X. | Petraglia, A. | Chen, M. | +3